Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease

18 Oct 2016

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) is an epidemic metabolic condition driven by an underlying lipid homeostasis disorder. The lipid droplet (LD), the main organelle involved in neutral lipid storage and hydrolysis, is a potential target for NAFLD therapeutic treatment. In this review, we summarize recent progress elucidating the connections between LD-associated proteins and NAFLD found by genome-wide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet, Metabolism, and Disease
Share to Lipid metabolism and biosynthesis
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27757845
DOI: 10.1007/s13238-016-0327-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver diseasePMID 27757845Read ↗

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.Semantic proximity Read ↗

Mechanisms of Lipid Droplet Accumulation in Steatotic Liver DiseasesSemantic proximity Read ↗

HSD17B13: A Potential Therapeutic Target for NAFLDSemantic proximity Read ↗

Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studiesSemantic proximity Read ↗

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity Read ↗

The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologiesSemantic proximity Read ↗

Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.Semantic proximity Read ↗

Genetics and epigenetics purpose in nonalcoholic fatty liver disease.Semantic proximity Read ↗

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and TherapeuticsSemantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

Proteomic Profiling of Lipid Droplet Proteins in Hepatoma Cell Lines Expressing Hepatitis C Virus Core ProteinSemantic proximity Read ↗

Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems BiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.